AD-SVF Therapy for Refractory Endometrial Infertility — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AD-SVF Therapy for Refractory Endometrial Infertility — Stella

Recruiting

Back to Endometrium; Atrophy trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Nanjing Drum Tower Hospital, Nanjing, Jiangsu

Key details

Phase

Early testing

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Enrollment target

~10 participants

Started

November 2025

Primary completion

December 2026

Age range

22 Years – 45 Years

Sex

Female only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov